+91-98 455 710 46 | info@nckpharma.com

Please sign in first

Username

Password

Lost Your Password?

Not a member?

Please simply create an account before buying/booking any courses.

Create an account for free!

Home
About Us
- Group of Companies
- Subscribe to free learning
NCK services
Course List
Admission
Knowledge Base
Contact

Home
About Us
- Group of Companies
- Subscribe to free learning
NCK services
Course List
Admission
Knowledge Base
Contact

Tag

ciraparantag

AMAG Pharmaceuticals to Acquire Perosphere and Its Anticoagulant

Posted on17 Dec 2018

TagsAmag, Amag Terminate Ferumoxytol Accord for EU, ciraparantag, Perosphere

Comments0

AMAG Pharmaceuticals, Inc. will acquire Perosphere Inc. to leverage its expertise in hematology. The deal will provide the company the rights to...

Our Popular Courses

Pharma Product Management
Digital Pharma Marketing
Strategic Management
Regulatory Affairs
Pharma Marketing
European DRA
Sales Management
Pharmacovigilance
Production Management
ASEAN DRA
GCC DRA
Pharma Project Management
Export Documentation

Recent Articles

What are the difference between Wholesaler and Specialty Pharmacy?
What is Scale-Up and Post Approval Changes (SUPAC) report?
What is the meaning of scale up in pharmaceutical industry?
RIL arm acquires stake in Strand Life Sciences for Rs. 393 crore
DRL enters agreement to sell its rights to anti-cancer agent E7777 to Citius Pharma
Takeda and Frazier announced a collaboration to launch HilleVax, Inc, a biopharmaceutical company, to develop and commercialize Takeda’s norovirus vaccine candidate
Nucala received USFDA approval to treat chronic rhinosinusitis with nasal polyps
Case Insight: Piramal Pharma’s acquisition of Hemmo Pharmaceuticals
FDC launches Favipiravir oral suspension to treat mild to moderate cases of COVID-19
Rossari Biotech to acquire Tristar Intermediates
Sun Pharma launches a special initiative ‘Sunkalp’ for the welfare of doctors
Case Insight – ANI Pharmaceuticals acquisition of Novitium Pharma
Astrazeneca has been given the all-clear to buy rare disease drug maker Alexion in a blockbuster £28billion deal.
Kintor Pharmaceutical collaborates with Fosun Pharma Development to Commercialise Proxalutamide
Codexis’s CodeEvolver platform technology transfer deal with Novartis
Lupin’s Somerset plant received US FDA warning letter for
What is Cytokine Storm?
FDA Grants Accelerated Approval for Alzheimer’s drug Aduhelm
Insight on Neurogastrx licensing deal with Daewoong Pharmaceutical to Develop Fexuprazan
Case study – Adagrasib out licensing deal

Course Category

KPE® – Certificate Program (1 Month)
KPE® – Certificate Program (1 Week)
KPE® – Publications / White Papers / Workshop / Others
KPE® Advance Diploma Program (1 Year Program)
KPE® Advance Diploma Program – Dual Specialization (1 Year Program)
KPE® Executive Program (1 Year Program)

NCK Pharma Solution Private Limited which is conceptualized in Year 2009 with a vision to spearhead innovation in the field of Pharmaceutical, Biotechnology, Medical Devices learning with the technological advances. The mission is to provide "Best On The Go" training services across those industries To Create, Develop, Train tomorrows Industry leaders.

GST No. 07AADCN2088D1ZM
PAN NO. AADCN2088D
CIN/ Foreign Company Registration Number: u74900dl2009ptc191741

Important URLs

Admission Process
Frequently asked question related to KPE courses
Prospect Identification Process
Verify Course Certificate
Request for Course Completion Certificate

Contact us

General Enquiry / Doubt clarification : info@nckpharma.com

Human Resource : HR@testnckpharma.com

To Escalate any issues: saikatroy@nckpharma.com

Frequently Asked Questions Related to course

Javascript is disabled

Javascript is disabled on your browser. Please enable it in order to use this form.

Loading

Query

First Name

Last Name

Email Address

Your Query *

Write Here

4 plus 7 equals?*

Prove you are a human

Write here

Your form has been submitted

Thank you %NAME% for the submitting your query/feedback.

Server Side Error

We faced problems while connecting to the server or receiving data from the server. Please wait for a few seconds and try again.

If the problem persists, then check your internet connectivity. If all other sites open fine, then please contact the administrator of this website with the following information.

TextStatus: undefined
HTTP Error: undefined

Processing your request

Error

Some error has occured.

Disclaimer & Privacy Policy | Terms of Use

Copyright © 2014 - 2015 All Right Reserved - NCK Pharma Solution Private Limited

This website uses cookies to improve your learning experience. Ok Privacy Policy

Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.

SAVE & ACCEPT

Scale up your Pharma knwledge to Next Level with our Free Content

Case studies & Caselets
Simulation based learning
Online self competency assessment tests

etc.